Ventricular arrhythmias in the context of chronic kidney disease and electrolyte imbalance.
Ventrikuläre Arrhythmien im Kontext von chronischer Nierenerkrankung und Elektrolytstörungen.
Dialysis
Electrolytes
Potassium
Sudden cardiac death
Ventricular tachycardia
Journal
Herzschrittmachertherapie & Elektrophysiologie
ISSN: 1435-1544
Titre abrégé: Herzschrittmacherther Elektrophysiol
Pays: Germany
ID NLM: 9425873
Informations de publication
Date de publication:
15 Jul 2024
15 Jul 2024
Historique:
accepted:
28
05
2024
medline:
15
7
2024
pubmed:
15
7
2024
entrez:
15
7
2024
Statut:
aheadofprint
Résumé
Patients with chronic kidney disease face a high risk of sudden cardiac death, particularly in more advanced stages of renal dysfunction. Ventricular arrhythmias are prevalent and contribute to the heightened cardiovascular mortality. This review aims to explore the intricate interplay of disease-specific risk factors, arrhythmic triggers, and electrolyte disorders that amplify susceptibility to ventricular arrhythmias and sudden cardiac death in this population and influence the efficacy of available treatments. Patienten mit chronischer Nierenerkrankung haben ein hohes Risiko für den plötzlichen Herztod, insbesondere in fortgeschrittenen Stadien der Nierenfunktionsstörung. Ventrikuläre Arrhythmien sind häufig und tragen zur erhöhten kardiovaskulären Mortalität bei. Diese Übersichtsarbeit untersucht das komplexe Zusammenspiel von krankheitsspezifischen Risikofaktoren, arrhythmogenen Triggern und Elektrolytstörungen, die die Anfälligkeit für ventrikuläre Arrhythmien und den plötzlichen Herztod in diesem Patientenkollektiv verstärken und gleichsam die Wirksamkeit verfügbarer Therapieoptionen beeinflussen.
Autres résumés
Type: Publisher
(ger)
Patienten mit chronischer Nierenerkrankung haben ein hohes Risiko für den plötzlichen Herztod, insbesondere in fortgeschrittenen Stadien der Nierenfunktionsstörung. Ventrikuläre Arrhythmien sind häufig und tragen zur erhöhten kardiovaskulären Mortalität bei. Diese Übersichtsarbeit untersucht das komplexe Zusammenspiel von krankheitsspezifischen Risikofaktoren, arrhythmogenen Triggern und Elektrolytstörungen, die die Anfälligkeit für ventrikuläre Arrhythmien und den plötzlichen Herztod in diesem Patientenkollektiv verstärken und gleichsam die Wirksamkeit verfügbarer Therapieoptionen beeinflussen.
Identifiants
pubmed: 39008102
doi: 10.1007/s00399-024-01029-7
pii: 10.1007/s00399-024-01029-7
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
Références
Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539
pubmed: 19007588
doi: 10.1016/j.jacc.2008.07.051
Rautavaara J et al (2022) Asystole episodes and bradycardia in patients with end-stage renal disease. Nephrol Dial Transplant 37:575–583
pubmed: 33527131
doi: 10.1093/ndt/gfab023
Bleyer AJ et al (2006) Characteristics of sudden death in hemodialysis patients. Kidney Int 69:2268–2273
pubmed: 16672908
doi: 10.1038/sj.ki.5000446
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305
pubmed: 15385656
doi: 10.1056/NEJMoa041031
Pun PH, Lehrich RW, Smith SR, Middleton JP (2007) Predictors of survival after cardiac arrest in outpatient hemodialysis clinics. Clin J Am Soc Nephrol 2:491–500
pubmed: 17699456
doi: 10.2215/CJN.02360706
Pun PH, Lehrich RW, Honeycutt EF, Herzog CA, Middleton JP (2011) Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int 79:218–227
pubmed: 20811332
doi: 10.1038/ki.2010.315
Stevens PE, Levin A (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158:825–830
pubmed: 23732715
doi: 10.7326/0003-4819-158-11-201306040-00007
Webster AC, Nagler EV, Morton RL, Masson P (2017) Chronic kidney disease. Lancet 389:1238–1252
pubmed: 27887750
doi: 10.1016/S0140-6736(16)32064-5
McDonough AA, Fenton RA (2022) Potassium homeostasis: sensors, mediators, and targets. Pflugers Arch 474:853–867
pubmed: 35727363
pmcid: 10163916
doi: 10.1007/s00424-022-02718-3
Dhondup T, Qian Q (2017) Electrolyte and acid-base disorders in chronic kidney disease and end-stage kidney failure. Blood Purif 43:179–188
pubmed: 28114143
doi: 10.1159/000452725
Cunningham J, Rodríguez M, Messa P (2012) Magnesium in chronic kidney disease stages 3 and 4 and in dialysis patients. Clin Kidney J 5:i39–i51
pubmed: 26069820
pmcid: 4455820
doi: 10.1093/ndtplus/sfr166
Cherry EM, Fenton FH, Gilmour RF Jr (2012) Mechanisms of ventricular arrhythmias: a dynamical systems-based perspective. Am J Physiol Heart Circ Physiol 302:H2451–2463
pubmed: 22467299
pmcid: 3378269
doi: 10.1152/ajpheart.00770.2011
Dursun B et al (2004) Effects of different dialysis modalities on cardiac autonomic dysfunctions in end-stage renal disease patients: one year prospective study. Ren Fail 26:35–38
pubmed: 15083919
doi: 10.1081/JDI-120028541
Robinson TG, Carr SJ (2002) Cardiovascular autonomic dysfunction in uremia. Kidney Int 62:1921–1932
pubmed: 12427117
doi: 10.1046/j.1523-1755.2002.00659.x
Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ (2003) Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol 14:425–430
pubmed: 12538743
doi: 10.1097/01.ASN.0000045049.72965.B7
Ligtenberg G et al (1999) Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 340:1321–1328
pubmed: 10219067
doi: 10.1056/NEJM199904293401704
Schiffrin EL, Lipman ML, Mann JF (2007) Chronic kidney disease: effects on the cardiovascular system. Circulation 116:85–97
pubmed: 17606856
doi: 10.1161/CIRCULATIONAHA.106.678342
Wu P, Vaseghi M (2020) The autonomic nervous system and ventricular arrhythmias in myocardial infarction and heart failure. Pacing Clin Electrophysiol 43:172–180
pubmed: 31823401
pmcid: 7723010
doi: 10.1111/pace.13856
Junho CVC, Frisch J, Soppert J, Wollenhaupt J, Noels H (2023) Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology. Clin Kidney J 16:1786–1803
pubmed: 37915935
pmcid: 10616472
doi: 10.1093/ckj/sfad085
Flinders DC, Roberts SD (2000) Ventricular arrhythmias. Prim Care 27:709–724
pubmed: 10918676
doi: 10.1016/S0095-4543(05)70170-6
El-Sherif N, Turitto G (2011) Electrolyte disorders and arrhythmogenesis. Cardiol J 18:233–245
pubmed: 21660912
Tang JKK, Rabkin SW (2022) Hypocalcemia-induced QT interval prolongation. Cardiology 147(2):191–195. https://doi.org/10.1159/000515985
doi: 10.1159/000515985
pubmed: 35078204
Liu P et al (2020) Acquired long QT syndrome in chronic kidney disease patients. Ren Fail 42:54–65
pubmed: 31878817
doi: 10.1080/0886022X.2019.1707098
Sarnak MJ et al (2019) Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 74:1823–1838
pubmed: 31582143
doi: 10.1016/j.jacc.2019.08.1017
Genovesi S et al (2021) Sudden cardiac death in dialysis patients: different causes and management strategies. Nephrol Dial Transplant 36:396–405
pubmed: 31538192
doi: 10.1093/ndt/gfz182
Zeppenfeld K et al (2022) 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 43:3997–4126
pubmed: 36017572
doi: 10.1093/eurheartj/ehac262
Fu L et al (2017) Do implantable cardioverter defibrillators reduce mortality in patients with chronic kidney disease at all stages? Int Heart J 58:371–377
pubmed: 28539571
doi: 10.1536/ihj.16-357
Franczyk B, Rysz J, Olszewski R, Gluba-Sagr A (2024) Do implantable cardioverter-defibrillators prevent sudden cardiac death in end-stage renal disease patients on dialysis? J Clin Med. https://doi.org/10.3390/jcm13041176
doi: 10.3390/jcm13041176
pubmed: 38398488
pmcid: 10889557
Caba B et al (2024) Cardiac device therapy in patients with chronic kidney disease: an update. J Clin Med. https://doi.org/10.3390/jcm13020516
doi: 10.3390/jcm13020516
pubmed: 38256650
pmcid: 10816721
Bansal N et al (2018) Long-term outcomes associated with Implantable cardioverter defibrillator in adults with chronic kidney disease. JAMA Intern Med 178:390–398
pubmed: 29404570
pmcid: 5885920
doi: 10.1001/jamainternmed.2017.8462
Hess PL et al (2014) Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease. Circ Arrhythm Electrophysiol 7:793–799
pubmed: 25038119
pmcid: 4206571
doi: 10.1161/CIRCEP.114.001455
Payne T et al (2020) Efficacy of Implantable cardioverter-defibrillators for secondary prevention of sudden cardiac death in patients with end-stage renal disease. J Innov Cardiac Rhythm Manage 11:4199–4208
doi: 10.19102/icrm.2020.110803
Kato S et al (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3:1526–1533
pubmed: 18701615
pmcid: 4571158
doi: 10.2215/CJN.00950208
Glikson M et al (2021) 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 42:3427–3520
pubmed: 34455430
doi: 10.1093/eurheartj/ehab364
Schiedat F et al (2024) Comparison of infection and complication rates associated with transvenous vs. subcutaneous defibrillators in patients with stage 4 chronic kidney disease: a multicenter long-term retrospective follow-up. Front Cardiovasc Med 11:1397138
pubmed: 38660482
pmcid: 11040078
doi: 10.3389/fcvm.2024.1397138
Boriani G et al (2015) Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making—a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace 17:1169–1196
pubmed: 26108808
pmcid: 6281310
doi: 10.1093/europace/euv202
Majeed H et al (2023) BRASH syndrome: a systematic review of reported cases. Curr Probl Cardiol 48:101663
pubmed: 36842470
doi: 10.1016/j.cpcardiol.2023.101663
Luciani R, Falcone C, Principe F, Punzo G, Menè P (2009) Acute renal failure due to amiodarone-induced hypothyroidism. Clin Nephrol 72:79–80
pubmed: 19640392
doi: 10.5414/CNP72079
Tschuppert Y et al (2007) Effect of dronedarone on renal function in healthy subjects. Br J Clin Pharmacol 64:785–791
pubmed: 17662087
pmcid: 2198776
doi: 10.1111/j.1365-2125.2007.02998.x
Pollak PT, Sharma AD, Carruthers SG (1993) Creatinine elevation in patients receiving amiodarone correlates with serum amiodarone concentration. Br J Clin Pharmacol 36:125–127
pubmed: 8398580
pmcid: 1364575
doi: 10.1111/j.1365-2125.1993.tb04207.x
Hall ME et al (2016) Beta-blocker use is associated with higher renal tissue oxygenation in hypertensive patients suspected of renal artery stenosis. Cardiorenal Med 6:261–268
pubmed: 27648007
pmcid: 5020395
doi: 10.1159/000445302
Fu EL et al (2020) Association between β‑blocker use and mortality/morbidity in patients with heart failure with reduced, midrange, and preserved ejection fraction and advanced chronic kidney disease. Circ Heart Fail 13:19
doi: 10.1161/CIRCHEARTFAILURE.120.007180
Bloom JE et al (2021) Adverse impact of chronic kidney disease on clinical outcomes following percutaneous coronary intervention. Catheter Cardiovasc Interv 97:E801–E809
pubmed: 33325620
doi: 10.1002/ccd.29436
Gupta T et al (2017) Association of chronic kidney disease with in-hospital outcomes of transcatheter aortic valve replacement. JACC Cardiovasc Interv 10:2050–2060
pubmed: 29050621
doi: 10.1016/j.jcin.2017.07.044
Gunda S et al (2019) Risk score model for predicting complications in patients undergoing ventricular tachycardia ablation: insights from the national inpatient sample database. Europace 21:475–483
pubmed: 30304357
doi: 10.1093/europace/euy213
Santangeli P et al (2017) Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease. J Am Coll Cardiol 69:2105–2115
pubmed: 28449770
doi: 10.1016/j.jacc.2017.02.044
Khalil M et al (2023) Impact of chronic kidney disease on in-hospital mortality and clinical outcomes of catheter ablation of ventricular tachycardia: insights from the national readmission database. J Interv Card Electrophysiol 66:323–331
pubmed: 35314904
doi: 10.1007/s10840-022-01187-z
Yu R et al (2015) Catheter ablation of scar-based ventricular tachycardia: relationship of procedure duration to outcomes and hospital mortality. Heart Rhythm 12:86–94
pubmed: 25285644
doi: 10.1016/j.hrthm.2014.10.004
Palevsky PM (2004) Perioperative management of patients with chronic kidney disease or ESRD. Best Pract Res Clin Anaesthesiol 18:129–144
pubmed: 14760878
doi: 10.1016/j.bpa.2003.08.003
Roberts PR, Green D (2011) Arrhythmias in chronic kidney disease. Heart 97:766–773
pubmed: 21474617
doi: 10.1136/hrt.2010.208587